Crossmark

Prognostic factors after imatinib secondary resistance: survival analysis in patients with unresectable and metastatic gastrointestinal stromal tumors

Crossref DOI link: https://doi.org/10.1007/s10147-015-0903-7

Published Online: 2015-09-19

Published Print: 2016-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Kanda, Tatsuo

Ishikawa, Takashi

Kosugi, Shin-ichi

Ueki, Kyo

Naito, Tetsuya

Wakai, Toshifumi

Hirota, Seiichi
Funding

Funding for this research was provided by:

Grant-in-Aid for Scientific Research from the Japan Society for Promotion of Science (24591934)
License Information

Text and Data Mining valid from 2015-09-19

Document is current

Any future updates will be listed below